Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,900 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Cancers, 2023Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin–Progranulin Axis in Breast Cancer
Berger K., Persson E., Gregersson P. et al.
Olink Target 96
Scientific Data, 2023A dataset of proteomic changes during human heat stress and heat acclimation
Gagnon D., Barry H., Barhdadi A. et al.
Olink Explore 3072/384
OncoImmunology, 2023Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases
Li M., Chen J., Yu H. et al.
Nature, 2023An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
LaMarche N., Hegde S., Park M. et al.
JCI Insight, 2023Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia
Englund D., Jolliffe A., Hanson G. et al.
Olink Target 96 Mouse
Clinical Cancer Research, 2023TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
Bessede A., Peyraud F., Besse B. et al.
European Journal of Heart Failure, 2023Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials
Ferreira J., Butler J., Anker S. et al.
eBioMedicine, 2023Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial
Zhang X., Irajizad E., Hoffman K. et al.
Scientific Reports, 2023Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome
Goudswaard L., Smith M., Hughes D. et al.
Cancers, 2023Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor
Stensgaard S., Thomsen A., Helstrup S. et al.
Nature Communications, 2023Plasma proteomic profiles predict individual future health risk
You J., Guo Y., Zhang Y. et al.
Circulation: Genomic and Precision Medicine, 2023Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation
Lind L., Titova O., Zeng R. et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2023Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank
Smith E., Lee J., Prilutsky D. et al.
ESC Heart Failure, 2023Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure
de Bakker M., Loncq de Jong M., Petersen T. et al.
Journal of Thrombosis and Haemostasis, 2023Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities
Yuan S., Xu F., Zhang H. et al.
Pediatric Research, 2023Antisecretory factor in breastmilk is associated with reduced incidence of sepsis in preterm infants
Gustafsson A., Johansson E., Henckel E. et al.
Nature Communications, 2023Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation
Mälarstig A., Grassmann F., Dahl L. et al.
Frontiers in Immunology, 2023Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay
Kmezic I., Gustafsson R., Fink K. et al.
iScience, 2023Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion
Moaddel R., Farmer C., Yavi M. et al.
Brain, 2023Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains
Quesnel M., Labonté A., Picard C. et al.
2996 publications
Items per page
861-880 of 2996 publications